This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Teva-Ranitidine (2016-06-09)
- Starting date:
- June 9, 2016
- Posting date:
- June 17, 2016
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-58946
Affected products
A. Teva-Ranitidine
Reason
Tablets were discoloured.
Depth of distribution
Pharmacies (AB, BC, MB, SK, ON, QC, NB, NS, NL)
Affected products
A. Teva-Ranitidine
DIN, NPN, DIN-HIM
00828556
Dosage form
Tablets
Strength
300mg
Lot or serial number
Lot 35341399A
Lot 35341400A
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA